These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


234 related items for PubMed ID: 24086492

  • 1. Detection of an extended human volatome with comprehensive two-dimensional gas chromatography time-of-flight mass spectrometry.
    Phillips M, Cataneo RN, Chaturvedi A, Kaplan PD, Libardoni M, Mundada M, Patel U, Zhang X.
    PLoS One; 2013; 8(9):e75274. PubMed ID: 24086492
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Evidence of endogenous volatile organic compounds as biomarkers of diseases in alveolar breath.
    Sarbach C, Stevens P, Whiting J, Puget P, Humbert M, Cohen-Kaminsky S, Postaire E.
    Ann Pharm Fr; 2013 Jul; 71(4):203-15. PubMed ID: 23835018
    [Abstract] [Full Text] [Related]

  • 4. Methods to Detect Volatile Organic Compounds for Breath Biopsy Using Solid-Phase Microextraction and Gas Chromatography-Mass Spectrometry.
    Schulz E, Woollam M, Grocki P, Davis MD, Agarwal M.
    Molecules; 2023 Jun 03; 28(11):. PubMed ID: 37299010
    [Abstract] [Full Text] [Related]

  • 5. Quantifying exhaled acetone and isoprene through solid phase microextraction and gas chromatography-mass spectrometry.
    Schulz E, Woollam M, Vashistha S, Agarwal M.
    Anal Chim Acta; 2024 May 01; 1301():342468. PubMed ID: 38553125
    [Abstract] [Full Text] [Related]

  • 6. Investigation of gender-specific exhaled breath volatome in humans by GCxGC-TOF-MS.
    Das MK, Bishwal SC, Das A, Dabral D, Varshney A, Badireddy VK, Nanda R.
    Anal Chem; 2014 Jan 21; 86(2):1229-37. PubMed ID: 24350824
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Analysis of volatile organic compounds in exhaled breath by gas chromatography-mass spectrometry combined with chemometric analysis.
    Dallinga JW, Smolinska A, van Schooten FJ.
    Methods Mol Biol; 2014 Jan 21; 1198():251-63. PubMed ID: 25270934
    [Abstract] [Full Text] [Related]

  • 10. Analysis of volatile organic compounds in the breath of patients with stable or acute exacerbation of chronic obstructive pulmonary disease.
    Pizzini A, Filipiak W, Wille J, Ager C, Wiesenhofer H, Kubinec R, Blaško J, Tschurtschenthaler C, Mayhew CA, Weiss G, Bellmann-Weiler R.
    J Breath Res; 2018 Mar 06; 12(3):036002. PubMed ID: 29295966
    [Abstract] [Full Text] [Related]

  • 11. A dual center study to compare breath volatile organic compounds from smokers and non-smokers with and without COPD.
    Gaida A, Holz O, Nell C, Schuchardt S, Lavae-Mokhtari B, Kruse L, Boas U, Langejuergen J, Allers M, Zimmermann S, Vogelmeier C, Koczulla AR, Hohlfeld JM.
    J Breath Res; 2016 Apr 15; 10(2):026006. PubMed ID: 27082437
    [Abstract] [Full Text] [Related]

  • 12. Method for the collection and assay of volatile organic compounds in breath.
    Phillips M.
    Anal Biochem; 1997 May 01; 247(2):272-8. PubMed ID: 9177688
    [Abstract] [Full Text] [Related]

  • 13. Comprehensive Two-Dimensional Gas Chromatography-Mass Spectrometry Analysis of Exhaled Breath Compounds after Whole Grain Diets.
    Raninen K, Nenonen R, Järvelä-Reijonen E, Poutanen K, Mykkänen H, Raatikainen O.
    Molecules; 2021 May 02; 26(9):. PubMed ID: 34063191
    [Abstract] [Full Text] [Related]

  • 14. Impact of breath sample collection method and length of storage of breath samples in Tedlar bags on the level of selected volatiles assessed using gas chromatography-ion mobility spectrometry (GC-IMS).
    Czippelová B, Nováková S, Šarlinová M, Baranovičová E, Urbanová A, Turianiková Z, Krohová JČ, Halašová E, Škovierová H.
    J Breath Res; 2024 May 17; 18(3):. PubMed ID: 38701772
    [Abstract] [Full Text] [Related]

  • 15. Headspace analysis of E-cigarette fluids using comprehensive two dimensional GC×GC-TOF-MS reveals the presence of volatile and toxic compounds.
    Patel D, Taudte RV, Nizio K, Herok G, Cranfield C, Shimmon R.
    J Pharm Biomed Anal; 2021 Mar 20; 196():113930. PubMed ID: 33581591
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Targeted volatolomics of human monocytes: Comparison of 2D-GC/TOF-MS and 1D-GC/Orbitrap-MS methods.
    Zemánková K, Pavelicová K, Pompeiano A, Mravcová L, Černý M, Bendíčková K, Hortová Kohoutková M, Dryahina K, Vaculovičová M, Frič J, Vaníčková L.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Nov 01; 1184():122975. PubMed ID: 34655893
    [Abstract] [Full Text] [Related]

  • 18. Relationship between cancer tissue derived and exhaled volatile organic compound from colorectal cancer patients. Preliminary results.
    De Vietro N, Aresta A, Rotelli MT, Zambonin C, Lippolis C, Picciariello A, Altomare DF.
    J Pharm Biomed Anal; 2020 Feb 20; 180():113055. PubMed ID: 31877489
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.